EMEA-000764-PIP01-09
Key facts
| Active substance |
4-Hydroxy-n-(2-hydroxyethyl)-butyramide
|
| Therapeutic area |
Anaesthesiology
|
| Decision number |
P/232/2010
|
| PIP number |
EMEA-000764-PIP01-09
|
| Pharmaceutical form(s) |
|
| Condition(s) / indication(s) |
Sedation
|
| Route(s) of administration |
Intravenous use
|
| Contact for public enquiries |
Dr. Franz Köhler Chemie GmbH
|
| Decision type |
RW: decision refers to a refusal on a request for waiver in all age groups for the listed condition(s)
|